GNH USA

Europe — EMA

Neuromiol (Rasagiline)

GNH USA supplies Neuromiol (Rasagiline), a monoamine oxidase B inhibitor for Parkinson's disease treatment. Request a quote for worldwide hospital supply.

Request sourcing

1
Pack/s

What is Rasagiline?

Rasagiline, the active ingredient in Neuromiol, is a monoamine oxidase B inhibitor presented as an oral tablet for oral use. It is indicated for the treatment of Parkinson's disease in adults. GNH USA supplies Neuromiol as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

What is Rasagiline used for?

Neuromiol, a monoamine oxidase B inhibitor, is employed in the management of Parkinson's disease and related therapeutic pathways.

Parkinson's disease (early-stage): improves motor symptoms and delays disease progression. Parkinson's disease (adjunct to levodopa): reduces off‑time and enhances overall motor control. Parkinson's disease (maintenance therapy): helps sustain dopamine levels for long‑term symptom control.

What are the side effects of Rasagiline?

Neuromiol may cause a range of adverse reactions that vary in frequency and severity.

Common Side Effects: - Nausea - Headache - Dizziness - Insomnia

Serious or Rare Side Effects: - Hypertension (sudden increase in blood pressure) - Hallucinations or psychotic episodes - Serotonin syndrome when combined with serotonergic agents - Severe liver injury - Allergic reactions such as rash or angioedema

What precautions apply to Rasagiline?

When prescribing Neuromiol, clinicians should consider several safety measures. - Dose adjustment: required in patients with renal impairment. - Monitor blood pressure: the drug may cause hypertension. - Avoid use with selective MAO‑A inhibitors: risk of hypertensive crisis. - Assess psychiatric status: may exacerbate hallucinations or depression. - Store at room temperature: keep in the original container, protect from moisture and direct sunlight.

What does Rasagiline interact with?

Neuromiol can interact with several medication classes, requiring careful management.

Major Interactions (Avoid): - Selective MAO‑A inhibitors: risk of hypertensive crisis. - Serotonergic antidepressants (e.g., SSRIs, SNRIs): risk of serotonin syndrome.

Moderate Interactions (Monitor Closely): - Levodopa: may enhance hypotensive effects. - Antihypertensive agents: additive blood pressure lowering. - Anticholinergic drugs: may increase anticholinergic burden.

Frequently asked questions

What is Neuromiol used for?+
Neuromiol contains rasagiline, which is prescribed to manage Parkinson's disease. It helps improve motor function, reduces stiffness, and can be used alone in early disease stages or as an add‑on to levodopa therapy in more advanced cases.
How does rasagiline work?+
Rasagiline irreversibly inhibits the MAO‑B enzyme in the brain, decreasing the breakdown of dopamine. Higher dopamine levels enhance neuronal signaling in pathways that control movement, thereby alleviating the motor symptoms of Parkinson's disease.
What is the usual dose of Neuromiol?+
The appropriate dose of Neuromiol is determined by the prescribing physician based on the patient’s clinical condition, disease stage, and response to therapy. Dosage may be adjusted over time, and patients should follow the prescriber’s instructions exactly.
Is Neuromiol safe in pregnancy or breastfeeding?+
Safety data for rasagiline during pregnancy and lactation are limited. It should only be used if the potential benefit justifies the potential risk to the fetus or infant, and the decision must be made by a qualified healthcare professional.
How do I order Neuromiol from GNH USA?+
To place an order, submit an enquiry on the Neuromiol product page at gnh-usa.com, specifying the required quantity. GNH USA works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.
How does Neuromiol compare with the main alternative drug or class?+
Neuromiol (rasagiline) and selegiline are both MAO‑B inhibitors used in Parkinson's disease. Rasagiline has a longer half‑life, requires once‑daily dosing, and is generally associated with a lower incidence of certain side effects such as orthostatic hypotension compared with selegiline.
How should Neuromiol be stored and handled?+
Neuromiol tablets should be stored at room temperature, below 25 °C, in the original blister pack to protect them from moisture and light. Keep the product out of reach of children and do not use if the packaging is damaged.
How is Neuromiol administered?+
Neuromiol is taken orally, usually once daily, with or without food. Patients should swallow the tablet whole with water and follow the dosing schedule prescribed by their healthcare provider.
What are the most serious risks to watch for while taking Neuromiol?+
Serious risks include sudden high blood pressure, hallucinations or other psychotic symptoms, serotonin syndrome when combined with serotonergic drugs, severe liver injury, and allergic reactions such as rash or swelling. Any of these symptoms should prompt immediate medical attention.
Who should not use Neuromiol?+
Neuromiol is contraindicated in patients with known hypersensitivity to rasagiline or any excipients, those taking other MAO‑A inhibitors, and individuals with severe liver impairment. Caution is also advised for patients with a history of psychiatric disorders or uncontrolled hypertension.
Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.

Product details

Drug
Rasagiline
Route
Oral Use
Manufacturer
Neuraxpharm Spain, S.L.U.
Origin
EU

Related products